In summary, our data demonstrate that increased levels of unprocessed MAM‐localized C99 are a driver of mitochondrial dysfunction in AD, mediated by the loss of sphingolipid homeostasis at ER–mitochondria connections. Here, APP is linked to Alzheimer disease.